Absorption of anti-blood group A antibodies on P-selectin glycoprotein ligand-1/immunoglobulin chimeras carrying blood group A determinants: Core saccharide chain specificity of the Se and H gene encoded α1,2 fucosyltransferases in different host cells

Glycobiology

Volumn 12, Issue 3, 2002, Pages 173-182

  Löfling, Jonas C ^a   Hauzenberger, Elenor ^a   Holgersson, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ABO incompatible; Alpha 1,2 fucosyltransferase; Antibody absorption; Glycoconjugate; Mucin

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP ANTIBODY; CARBOHYDRATE; COMPLEMENTARY DNA; EPITOPE; FUCOSYLTRANSFERASE; GLASS; IMMUNOGLOBULIN G2B; MUCIN; N ACETYLGALACTOSAMINYLTRANSFERASE; NEURAMINIC ACID DERIVATIVE; P SELECTIN GLYCOPROTEIN LIGAND 1; RECOMBINANT ANTIBODY; RECOMBINANT PROTEIN; TRISACCHARIDE;

ANIMAL CELL; ARTICLE; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP O; BONE MARROW TRANSPLANTATION; CELL STRAIN COS7; CHIMERA; CHO CELL; CONTROLLED STUDY; COVALENT BOND; DENSITY GRADIENT; GENETIC CODE; GENETIC TRANSFECTION; HOST CELL; HUMAN; HUMAN CELL; IMMUNOADSORPTION; KIDNEY CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; RECIPIENT; WESTERN BLOTTING;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0036259293     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/12.3.173     Document Type: Article

References (58)

1. Characterization of the O-linked oligosaccharide structures on P-selectin glycoprotein ligand-1 (PSGL-1)
2. Partial characterization of the N-linked oligosaccharide structures on P-selectin glycoprotein ligand-1 (PSGL-1)
3. Renal transplantation across the ABO barrier using A2 kidneys
4. ABO-incompatible bone marrow transplantation: The transfusion of incompatible plasma may exacerbate regimen-related toxicity
5. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation
6. Plasma exchange and immunoadsorption for removal of antibodies prior to ABO incompatible bone marrow transplant
7. Immunoadsorption for removal of A and B blood-group antibodies
8. In vitro and in vivo removal of anti-A erythrocyte antibody by adsorption to a synthetic immunoadsorbent
9. Removal of specific antibody in vivo by whole blood immunoadsorption: Preliminary results in dogs
10. Plasma exchange and plasma modification for the removal of anti-red cell antibodies prior to ABO-incompatible marrow transplant
11. Variant forms of alpha1, 2fucosyltransferase in human submaxillary glands from blood group ABH "secretor" and "non-secretor" individuals
12. Purification to homogeneity of H blood group beta-galactoside alpha 1 leads to 2 fucosyltransferase from porcine submaxillary gland
13. Cell surface mucin-type glycoproteins and mucin-like domains
14. Expression of human alpha-1-fucosyl-transferase gene homologs in monkey kidney COS cells and modification of potential fucosyltransferase acceptor substrates by an endogenous glycosidase
15. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution
16. Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejection-experience with ABO-incompatible cardiac allografting in the baboon
17. A-active trisaccharides isolated from A1 and A2 blood-group-specific glycoproteins
18. Liver transplantation across the ABO barrier: The role of plasmapheresis
19. Stable expression of blood group H determinants and GDP-L-fucose: Beta-D-galactoside 2-alpha-L-fucosyltransferase in mouse cells after transfection with human DNA
20. The use of ABO-incompatible grafts in liver transplantation: A life-saving procedure in highly selected patients
21. ABO blood group system and bone marrow transplantation
22. Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides
23. Waiting for organ transplantation
24. Liver transplantation across ABO blood group barriers
25. Antigen structure and genetic basis of histo-blood groups A, B and O: Their changes associated with human cancer
26. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids
27. Experience of ABO-incompatible living kidney transplantation after double filtration plasmapheresis
28. Sequence and expression of a candidate for the human Secretor blood group alpha(1, 2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype
29. Biochemical evidence that secretor gene, Se, is a structural gene encoding a specific fucosyltransferase
30. Purification of the blood group H gene associated alpha-2-L-fucosyltransferase from human plasma
31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
32. Molecular cloning, sequence, and expression of a human GDP-L- fucose: Beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen
33. The presence of at least two different H-blood-group-related beta-D-gal alpha-2-L-fucosyltransferases in human serum and the genetics of blood group H substances
34. Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Ga1 alpha 1, 3Gal epitope
35. Presence of H type 3/4 chains of ABO histo-blood group system in serous cells of human submandibular gland and regulation of their expression by the secretor gene (FUT2)
36. Distribution of H type 1 and of H type 2 antigens of ABO blood group in different cells of human submandibular gland
37. Structures common to different types of glycans
38. Morphological aspects of renal homograft rejection
39. Expression of human H-type alpha1, 2-fucosyltransferase encoding for blood group H(O) antigen in Chinese hamster ovary cells. Evidence for preferential fucosylation and truncation of polylactosamine sequences
40. Remodeling of mouse milk glycoconjugates by transgenic expression of a human glycosyltransferase
41. A cloned human DNA restriction fragment determines expression of a GDP-L-fucose: Beta-D-galactoside 2-alpha-L-fucosyltransferase in transfected cells. Evidence for isolation and transfer of the human H blood group locus
42. In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents
43. Molecular cloning of a human genomic region containing the H blood group alpha(1, 2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus
44. Increased bile duct complications in liver transplantation across the ABO barrier
45. Purification of the secretor-type beta-galactoside alpha 1-2-fucosyltransferase from human serum
46. Purification of H gene-encoded beta-galactoside alpha 1-2 fucosyltransferase from human serum
47. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2
48. Cell adhesion. Mucins in the mainstream
49. In vivo glycosylation of mucin tandem repeats
50. Intravenous infusion of Galalpha1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts
51. The sugar chain structures of ABO blood group active glycoproteins obtained from human erythrocyte membrane
52. Cryofiltration apheresis for major ABO-incompatible kidney transplantation
53. Long-term results of ABO-incompatible living kidney transplantation: A single-center experience
54. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells
55. Molecular genetic basis of the histo-blood group ABO system
56. Cardiac allotransplantation across the ABO-blood group barrier by the neutralization of preformed antibodies: The baboon as a model for the human
57. Novel sulfated lymphocyte homing receptors and their control by a core 1 extension beta 1, 3-N-acetylglucosaminyltransferase
58. Alpha(1, 2)-fucosylation prevents sialyl Lewis x expression and E-selectin-mediated adhesion of fucosyltransferase VII-transfected cells